RESUMO
Febrile nonhemolytic and allergic reactions are the most common transfusion reactions, but usually do not cause significant morbidity. In an attempt to prevent these reactions, US physicians prescribe acetaminophen or diphenhydramine premedication before more than 50% of blood component transfusions. Acetaminophen and diphenhydramine are effective therapies for fever and allergy, respectively, so their use in transfusion has some biologic rationale. However, these medications also have potential toxicity, particularly in ill patients, and in the studies performed to date, they have failed to prevent transfusion reactions. Whether the benefits of routine prophylaxis with acetaminophen and diphenhydramine outweigh their risks and cost requires reexamination, particularly in light of the low reaction rates reported at many institutions even when premedication is not prescribed.
Assuntos
Acetaminofen/uso terapêutico , Analgésicos não Narcóticos/uso terapêutico , Antialérgicos/uso terapêutico , Transfusão de Componentes Sanguíneos/efeitos adversos , Difenidramina/uso terapêutico , Hipersensibilidade/prevenção & controle , Acetaminofen/efeitos adversos , Acetaminofen/economia , Analgésicos não Narcóticos/efeitos adversos , Analgésicos não Narcóticos/economia , Antialérgicos/efeitos adversos , Transfusão de Componentes Sanguíneos/economia , Transfusão de Componentes Sanguíneos/mortalidade , Difenidramina/efeitos adversos , Difenidramina/economia , Febre/economia , Febre/etiologia , Febre/mortalidade , Febre/prevenção & controle , Humanos , Hipersensibilidade/economia , Hipersensibilidade/etiologia , Hipersensibilidade/mortalidadeAssuntos
Transtornos da Coagulação Sanguínea/mortalidade , Transfusão de Componentes Sanguíneos/mortalidade , Ressuscitação/mortalidade , Ferimentos e Lesões/mortalidade , Transtornos da Coagulação Sanguínea/economia , Transtornos da Coagulação Sanguínea/etiologia , Transtornos da Coagulação Sanguínea/terapia , Transfusão de Componentes Sanguíneos/efeitos adversos , Transfusão de Componentes Sanguíneos/economia , Humanos , Ferimentos e Lesões/terapiaRESUMO
OBJECTIVE: To receive and collate reports of death or major complications of transfusion of blood or components. DESIGN: Haematologists were invited confidentially to report deaths and major complications after blood transfusion during October 1996 to September 1998. SETTING: Hospitals in United Kingdom and Ireland. SUBJECTS: Patients who died or experienced serious complications, as defined below, associated with transfusion of red cells, platelets, fresh frozen plasma, or cryoprecipitate. MAIN OUTCOME MEASURES: Death, "wrong" blood transfused to patient, acute and delayed transfusion reactions, transfusion related acute lung injury, transfusion associated graft versus host disease, post-transfusion purpura, and infection transmitted by transfusion. Circumstances relating to these cases and relative frequency of complications. RESULTS: Over 24 months, 366 cases were reported, of which 191 (52%) were "wrong blood to patient" episodes. Analysis of these revealed multiple errors of identification, often beginning when blood was collected from the blood bank. There were 22 deaths from all causes, including three from ABO incompatibility. There were 12 infections: four bacterial (one fatal), seven viral, and one fatal case of malaria. During the second 12 months, 164/424 hospitals (39%) submitted a "nil to report" return. CONCLUSIONS: Transfusion is now extremely safe, but vigilance is needed to ensure correct identification of blood and patient. Staff education should include awareness of ABO incompatibility and bacterial contamination as causes of life threatening reactions to blood.